SABSW
SAB Biotherapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:B
Company Profile
CEO
Samuel J. Reich
IPO Date
2021-10-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
SAB Biotherapeutics, Inc.
CEO
Samuel J. Reich
IPO Date
2021-10-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US